DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma. - Wikidata - wikimedia - TriplyDB

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

http://www.wikidata.org/entity/Q37097138

about

A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis DNA methylation changes in epithelial ovarian cancer histotypes.Expression pattern of the class I homeobox genes in ovarian carcinoma.Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer Ovarian stem cells: From basic to clinical applications.MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions.Lessons from senescence: Chromatin maintenance in non-proliferating cells.Role of epigenomics in ovarian and endometrial cancers.Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.Epigenetic biomarkers in the diagnosis of ovarian cancer.Unexpected functional similarities between gatekeeper tumour suppressor genes and proto-oncogenes revealed by systems biology.Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis.Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.Aberrant Methylation Changes Detected in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals.A computational framework for complex disease stratification from multiple large-scale datasets.

P2860

Q26746952-CF0FE962-407E-489E-9792-F6C3EE3868BD Q27690722-37B0DAC9-41E0-4CFD-BA1B-42E4DEEC0EBE Q33771207-A3EABB61-0D42-4D77-BA17-C53C942A0598 Q34361640-868AE4BC-F81D-4927-90F5-934ACB5FEA05 Q34429176-5AF20FB4-03A2-40AC-B5E1-2C043E723B35 Q34711457-1C1B36FB-D76B-4CF8-8F65-6389609513CF Q35649789-82DC7834-83EA-47DE-BF6C-2208A95FC9B4 Q36253778-EE77EB37-CE82-442C-837C-753D43A7AA87 Q36415124-7512F90A-F75C-4BB5-9098-4B126835EB4A Q37374050-40211974-220F-4FA8-9E22-65DA03D7333A Q37492907-0876A0F1-737C-4504-BC04-9EAFC012D7EC Q37961734-A9DE99F8-2689-419A-8006-FAD1EB9725DA Q37962013-BF5D4D09-DA8E-4112-B3C1-F6649DE42A1D Q39453522-49E5D2C0-6B03-494E-A21D-724632B81208 Q42692889-2BE976D0-C983-4D09-87CF-C37D8A6BB484 Q47410163-4E615F1F-2B00-47BC-93F3-61252ABC1AD7 Q54204521-4497100C-4424-459B-AD10-5F980158CCCD Q55068767-7EB38B85-F0B9-43E5-8D6C-7D0C43449138 Q55139050-E6EA4F17-E1CA-4C89-8180-B989DF7F0F10

P2860

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

http://www.wikidata.org/entity/Q37097138

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@en

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@nl

type

label

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@en

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@nl

prefLabel

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@en

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@nl

P1433

Q37097138-2C9FE7D9-5B7C-4F0A-B6BE-02D28F932AE7

P1476

Q37097138-B1C78A17-6243-4DB7-9765-85E12169AA0C

P2093

Q37097138-09AE984E-D02D-4E1E-8901-4C5AF7BDAF4E

Q37097138-0A84BCA4-2571-47D9-A75D-2DE9D119A859

Q37097138-14062B74-47E9-4F72-9B19-078F95811E33

Q37097138-51B82B67-F2C3-4B17-A620-6BA42E4BC1FE

Q37097138-5E5D452C-A55E-4A59-BD50-F1587D17DF04

Q37097138-86EA9743-F4E9-49CB-8113-F5CD49635BC7

Q37097138-AB94A735-F144-4D0A-ACF9-C6187E0F1F9F

Q37097138-C895564D-AD0E-45B2-AD6D-10F390D9BD9E

Q37097138-DF1EC3DB-CFC9-41D4-8017-AE1F2E15AE63

Q37097138-FA10C3D2-A175-49F4-9473-D15072F276C7

P2860

Q37097138-08412593-2460-4B9C-83F8-FABAA5210E04

Q37097138-0C45E9E9-C12F-4308-96C1-4D41BCC78710

Q37097138-3979F7E0-78D8-403F-A0B3-B944E986AF46

Q37097138-3EB59865-C1F2-4311-A2BF-73403428F131

Q37097138-40CA6F19-5197-4F26-AF66-87E5F2C14767

Q37097138-42279413-7A28-4823-BB8D-D22538E187C0

Q37097138-42FB8E47-1B32-4B3C-986F-16E1ABA68C58

Q37097138-47A834EB-9075-44ED-804C-0CCF1D0525E7

Q37097138-4A4E71C9-FD06-4561-8402-99A5E0017894

Q37097138-54BD51AC-EF06-4AC6-BD33-51608EC75A6B

P304

Q37097138-FE36F2BC-704B-4303-8DD9-4134C33E088A

P31

Q37097138-9C44DF7C-E580-4FCA-BEB8-7D511182B839

P356

Q37097138-32ACE69A-A409-44AF-A0BE-741EA0C9C3EA

P407

Q37097138-B09304BC-896C-40A6-8AB6-77302CC29F86

P433

Q37097138-78066F60-7F72-40F4-BBBB-DA068007C5AD

P478

Q37097138-17045BBB-B425-400E-AAD6-BA3A25412555

P577

Q37097138-25C8DEE1-7B32-45ED-8AB8-A92C00242406

P5875

Q37097138-A2D15AF5-B14D-4F9A-9641-3DDBFEDC4597

P698

Q37097138-432E14E0-6D86-4CDE-9662-B1A6B04C6D9F

P921

Q37097138-3C3C7494-F851-447A-B379-35721457C39D

P932

Q37097138-FF49E4AE-2C47-453C-8C87-5B94F3C5AEE0

P356

J.YGYNO.2008.07.036

P1433

Gynecologic Oncology

P1476

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

@en

P2093

Charles Drescher

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Swisher

http://www.w3.org/2001/XMLSchema#string

Georgios Deftereos

http://www.w3.org/2001/XMLSchema#string

Joshua E Stern

http://www.w3.org/2001/XMLSchema#string

Julia B Willner

http://www.w3.org/2001/XMLSchema#string

Longfu Xi

http://www.w3.org/2001/XMLSchema#string

Nancy Kiviat

http://www.w3.org/2001/XMLSchema#string

Nicole Urban

http://www.w3.org/2001/XMLSchema#string

Qinghua Feng

http://www.w3.org/2001/XMLSchema#string

Stephen E Hawes

http://www.w3.org/2001/XMLSchema#string

P2860

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily

Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma

Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Gene silencing in cancer in association with promoter hypermethylation

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.

Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.

P304

320-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2008.07.036

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23223440

http://www.w3.org/2001/XMLSchema#string

P698

18757082

http://www.w3.org/2001/XMLSchema#string

P921

P932

2642648

http://www.w3.org/2001/XMLSchema#string